英文名稱 |
中文名稱 |
CAS號 |
操作 |
LX 1606 Hippurate |
4-[2-氨基-6-[(1R)-1-[4-氯-2-(3-甲基-1H-吡唑-1-基)苯基]-2,2,2-三氟乙氧基]-4-嘧啶基]-L-苯丙氨酸乙酯 N-苯甲酰甘氨酸鹽 |
1137608-69-5 |
詳細(xì)
|
UNC1999 |
UNC1999 |
1431612-23-5 |
詳細(xì)
|
2-(4-((9S,13S)-9,13-Bis(Tert-Butoxycarbonyl)-18,18-Dimethyl-3,11,16-Trioxo-17-Oxa-2,4,10,12-Tetraazanonadecyl)Phenyl)Acetic Acid |
PSMA-ligand-1 |
1610413-97-2 |
詳細(xì)
|
1,2,3,4,5,6-Benzenehexamine |
六氨基苯(3鹽酸鹽) |
4444-26-2 |
詳細(xì)
|
2-azido-2-deoxy-D-mannose |
|
97604-58-5 |
詳細(xì)
|
Fmoc-Phe-Lys(Boc)-PAB-PNP |
FMOC-PHE-LYS(BOC)-PAB-PNP |
1646299-50-4 |
詳細(xì)
|
RGD(DY)K, RGD cyclic peptide |
RGD(D-Y)K,RGD環(huán)肽 |
|
詳細(xì)
|
MAC-545496 |
MAC-545496 |
838810-96-1 |
詳細(xì)
|
Tubulin inhibitor 6 |
Tubulin inhibitor 6 |
105925-39-1 |
詳細(xì)
|
2-BROMO-5-METHOXYBENZONITRILE |
2-溴-5-甲氧基苯甲腈 |
138642-47-4 |
詳細(xì)
|
1-(4-BROMOPHENYL)CYCLOBUTANAMINE (HYDROCHLORIDE) |
1-(4-溴苯基)環(huán)丁胺鹽酸鹽 |
1193389-40-0 |
詳細(xì)
|
Tert-Butyl1-(4-Bromophenyl)cyclobutylcarbamate |
1-(4-溴苯基)環(huán)丁基]氨基甲酸叔丁酯 |
1032350-06-3 |
詳細(xì)
|
VLX600 |
VLX600 |
1622945-04-3 |
詳細(xì)
|
Inarigivir (ORI-9020, SB-9000) |
SB9000 |
475650-36-3 |
詳細(xì)
|
LYN-1604 hydrochlorate |
LYN-1604 HYDROCHLORIDE |
2216753-86-3 |
詳細(xì)
|
NS-398 |
抑制劑 |
123653-11-2 |
詳細(xì)
|
P-MPPI MONOHYDROCHLORIDE |
P-MPPI MONOHYDROCHLORIDE |
220643-77-6 |
詳細(xì)
|
1,3,5-ADAMANTANETRIOL |
1,3,5-金剛烷三醇 |
99181-50-7 |
詳細(xì)
|
CH-223191 |
1-甲基-N-[2-METHYL-4-[2-(2-甲苯基)二氮烯基]苯基-1H-吡唑-5-甲酰胺 |
301326-22-7 |
詳細(xì)
|
RHPS4 |
RHPS4 |
390362-78-4 |
詳細(xì)
|
5-Chloropyrimidine-2-Carboxylic Acid Methyl Ester |
5-氯嘧啶-2-羧酸甲酯 |
894797-00-3 |
詳細(xì)
|
1-(4-nitrophenyl)cyclobutan-1-amine |
1-(4-硝基苯基)環(huán)丁胺 |
1260672-25-0 |
詳細(xì)
|
1G244 |
(S)-2-Amino-4-(4-(bis(4-fluorophenyl)methyl)piperazin-1-yl)-1-(isoindolin-2-yl)butane-1,4-dione |
847928-32-9 |
詳細(xì)
|
2-Amino-4-methoxypyridine |
2-氨基-4-甲氧基吡啶 |
10201-73-7 |
詳細(xì)
|
Pregabalin Impurity 19 |
(R)-2-羥基-2-苯基乙酸異丙酯 |
89015-27-0 |
詳細(xì)
|
TH5487 |
TH 5487 |
2304947-71-3 |
詳細(xì)
|
BI-3406 |
BI-3406 |
2230836-55-0 |
詳細(xì)
|
4,7,10,13-Tetraoxapentadecanoic acid, 15-amino-, methyl ester |
4,7,10,13-Tetraoxapentadecanoic acid, 15-amino-, methyl ester |
1263044-69-4 |
詳細(xì)
|
DGY-06-116 |
DGY-06-116 |
2556836-50-9 |
詳細(xì)
|
Fmoc-Val-MC-Phe-PAB-Lys(Trt)-ONAla-PAB-OH |
|
|
詳細(xì)
|
metipranolol |
美替洛爾 |
22664-55-7 |
詳細(xì)
|
3-(4-CHLOROPHENYL)PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER |
3-(4-氯苯基)哌嗪-1-甲酸叔丁酯 |
886767-49-3 |
詳細(xì)
|
Emapunil |
AC-5216 |
226954-04-7 |
詳細(xì)
|
ADU-S100 ammonium salt |
ADU-S100銨鹽 |
1638750-96-5 |
詳細(xì)
|
Valnivudine |
伐尼夫定 |
956483-03-7 |
詳細(xì)
|
18-(4-(5,5-difluoro-5H-4l4,5l4-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-10-yl)phenyl)octadecyl (2-(trimethylammonio)ethyl) phosphat |
CLR1501 |
1250963-36-0 |
詳細(xì)
|
6-Chloropyridazine-3-carboxylic acid |
6-氯噠嗪-3-羧酸 |
5096-73-1 |
詳細(xì)
|
TRi-1 |
TRi-1 |
246020-68-6 |
詳細(xì)
|
Pifithrin-μ |
PHENYLETHYNSULFONIC ACID AMIDE |
64984-31-2 |
詳細(xì)
|
RGD(DF)C, RGD cyclic peptide |
RGD(D-F)C,RGD環(huán)肽 |
|
詳細(xì)
|
IM156 |
IM156 |
1422365-93-2 |
詳細(xì)
|
METHYL 6-CHLOROPYRIDAZINE-3-CARBOXYLATE |
6-氯噠嗪-3-甲酸甲酯 |
65202-50-8 |
詳細(xì)
|
Aurora kinase inhibitor III |
AURORA KINASE INHIBITOR III |
879127-16-9 |
詳細(xì)
|
(R)-4-Isobutylpyrrolidin-2-one |
(R)-4-異丁基吡咯烷-2-酮 |
181289-22-5 |
詳細(xì)
|
HM30181 (Mesylate) |
849675-87-2 |
849675-87-2 |
詳細(xì)
|
PFK158 |
PFKFB3抑制劑(PFK-158) |
1462249-75-7 |
詳細(xì)
|
ODM-201 |
達(dá)洛魯胺 |
1297538-32-9 |
詳細(xì)
|
Benzo[b]thien-2-yl Ketone |
絲裂霉素雜質(zhì) |
97978-07-9 |
詳細(xì)
|
IU1-47 |
IU1-47 |
670270-31-2 |
詳細(xì)
|
2,2,4,4,6,6-HEXAKIS-(4-BROMO-PHENOXY)-,,-(1,3,5,2,4,6)TRIAZATRIPHOSPHINI NE |
4376-72-1游離 |
4376-72-1 |
詳細(xì)
|
STING agonist-4 |
STING AGONIST-4 |
2138300-40-8 |
詳細(xì)
|
R configuration CPI169 |
R構(gòu)型 CPI169 |
|
詳細(xì)
|
BO-264 |
BO-264 |
2408648-20-2 |
詳細(xì)
|
GSK620 |
GSK620 |
2088410-46-0 |
詳細(xì)
|
Fmoc-Phe-Lys(Trt)-PAB |
L-Lysinamide, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-phenylalanyl-N-[4-(hydroxymethyl)phenyl]-N6-(triphenylmethyl)- |
1116085-98-3 |
詳細(xì)
|
AM1241 |
AM-1241 |
444912-48-5 |
詳細(xì)
|
3-Pyridinecarboxylic acid, 5-chloro-2-methyl- |
5-氯-2-甲基-3-吡啶羧酸 |
1092286-30-0 |
詳細(xì)
|
CDKI-73 |
CS-2259 |
1421693-22-2 |
詳細(xì)
|
AZD3759 |
AZD3759 |
1626387-80-1 |
詳細(xì)
|
BAY 61-3606 (hydrochloride) |
BAY 61-3606 (HYDROCHLORIDE) |
1615197-10-8 |
詳細(xì)
|
MSAB |
MSAB |
173436-66-3 |
詳細(xì)
|
2-CHLORO-5-NITROPYRIMIDIN-4-AMINE |
2-氯-4-氨基-5-硝基嘧啶 |
1920-66-7 |
詳細(xì)
|
ZT-12-037-01 |
ZT-12-037-01 |
2328073-61-4 |
詳細(xì)
|
MC-Gly-Gly-Phe |
MC-GLY-GLY-PHE |
1599440-15-9 |
詳細(xì)
|
NS-3-008(HCl) |
NS-3-008(HCl) |
1172854-54-4 |
詳細(xì)
|
Guanosine, N-(2-methyl-1-oxopropyl)-, 2',3'-bis(2-methylpropanoate) |
Guanosine, N-(2-methyl-1-oxopropyl)-, 2',3'-bis(2-methylpropanoate) |
56489-75-9 |
詳細(xì)
|
(±)-Ibipinabant |
362519-49-1 |
362519-49-1 |
詳細(xì)
|
Rigosertib sodium |
瑞格色替鈉 |
592542-60-4 |
詳細(xì)
|
Phe-Lys(Trt)-PAB |
Phe-Lys(Trt)-PAB |
1116085-99-4 |
詳細(xì)
|
BRD7552 |
BRD7552 |
1137359-47-7 |
詳細(xì)
|
SBC-115076 |
sbc-115076 |
489415-96-5 |
詳細(xì)
|
2-Pyrrolidinepropanoic acid, 1-[(1,1-dimethylethoxy)carbonyl]-β-methoxy-α-methyl-, (αR,βR,2S)-, compd. with N-cyclohexylcyclohexanamine (1:1) |
二環(huán)己胺(2R,3R)-3-((S)-1-(叔丁氧基羰基)吡咯烷-2-基)-3-甲氧基-2-甲基丙酸酯 |
1369427-40-6 |
詳細(xì)
|
IDF-11774 |
化合物IDF-11774 |
1429054-28-3 |
詳細(xì)
|
NDI-091143 |
NDI-091143 |
2375840-87-0 |
詳細(xì)
|
INCB086550 |
GNE-8324 |
2378608-10-5 |
詳細(xì)
|
Pregabalin EP Impurity A |
(S)-4-異丁基吡咯烷-2-酮 |
181289-23-6 |
詳細(xì)
|
N-(8-Amino-6-fluoro-5-methyl-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)acetamide |
N-(8-氨基-6-氟-5-甲基-1-氧代-1,2,3,4-四氫萘-2-基)乙酰胺 |
182182-31-6 |
詳細(xì)
|
ML-109 |
ML-109 |
1186649-91-1 |
詳細(xì)
|
Pregabalin Impurity D |
普瑞巴林雜質(zhì)D |
53439-96-6 |
詳細(xì)
|
4-Chloropyridine-2-carboxamide |
4-氯吡啶-2-甲酰胺 |
99586-65-9 |
詳細(xì)
|
1-(4-BROMOPHENYL)CYCLOBUTANECARBOXYLIC ACID |
1-(4-溴苯基)環(huán)丁烷羧酸 |
151157-49-2 |
詳細(xì)
|
LDC203974(IMT1B) |
化合物IMT1B |
2304621-06-3 |
詳細(xì)
|
ALC-0315 |
ALC-0315 |
2036272-55-4 |
詳細(xì)
|
APY0201 |
化合物APY0201 |
1232221-74-7 |
詳細(xì)
|
Emixustat Hydrochloride |
特戈拉贊 |
942195-55-3 |
詳細(xì)
|
Hexanoicacid, 3-(2-amino-2-oxoethyl)-5-methyl-, (3S)- |
普瑞巴林雜質(zhì)10 |
181289-34-9 |
詳細(xì)
|
Lazertinib |
YH-25448 |
1903008-80-9 |
詳細(xì)
|
V-9302 |
V-9302 |
1855871-76-9 |
詳細(xì)
|
MC-GGFG |
|
1599490-25-1 |
詳細(xì)
|
5-Pyrimidinecarboxylic acid, 1,4-dihydro-4-oxo- (9CI) |
6-氧代-1,6-二氫嘧啶-5-甲酸 |
65754-04-3 |
詳細(xì)
|
C75 |
反-4-羧基-5-辛基-3-甲基-丁內(nèi)酯 |
191282-48-1 |
詳細(xì)
|
ML-SA1 |
2-[2-氧代-2-(2,2,4-三甲基-3,4-二氫-2H-喹啉-1-基)-乙基]-異吲哚-1,3-二酮 |
332382-54-4 |
詳細(xì)
|
SAR 131675 |
SAR131675 |
1433953-83-3 |
詳細(xì)
|
Imiquimod hydrochloride |
鹽酸咪喹莫特 |
99011-78-6 |
詳細(xì)
|
TAS-115 |
1190836-34-0 |
1190836-34-0 |
詳細(xì)
|
SJA710-6 |
SJA710-6 |
1397255-09-2 |
詳細(xì)
|
ERK5-IN-2 |
ERK5-IN-2 |
1888305-96-1 |
詳細(xì)
|
CH6953755 |
CH6953755 |
2055918-71-1 |
詳細(xì)
|
NV-5138 |
Pentanoic acid, 2-amino-5,5-difluoro-4,4-dimethyl-, (2S)- |
2095886-80-7 |
詳細(xì)
|
RGD(DF)K, RGD cyclic peptide |
RGD(D-F)K,RGD環(huán)肽 |
|
詳細(xì)
|